MFDS
- Status: likely_approved
🇰🇷 Candesartan Cilexetil in South Korea
Candesartan Cilexetil (CILEXETIL) regulatory status in South Korea.
Marketing authorisation
Candesartan Cilexetil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Candesartan Cilexetil approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Candesartan Cilexetil in South Korea?
Alembic is the originator. The local marketing authorisation holder may differ — check the official source linked above.